HT

Heikrujam Thoihen Meitei

Also known as: Thoihen

Roswell Park Comprehensive Cancer, National Centre for Cell Science

ORCID iD 0000-0003-1605-0849

About

Heikrujam Thoihen Meitei currently works at the Department of Medicine Roswell Park Cancer Center, Buffalo, New York as a Research Affiliate (Post-Doc). He obtained his PhD degree in Biotechnology from National Centre For Cell Science, Pune, India. Thoihen is currently working on CAR T cells. Thoihen did his PhD research in Autoimmunity, Molecular Biology and Cell Biology. Their most recent publication is 'CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation.' and 'CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.'

Employment

  • Roswell Park Comprehensive Cancer Research Affiliate (Post-Doc)
    2022 - 2027
  • National Centre for Cell Science SRF
    2016 - 2022
  • National Centre for Cell Science SRF
    2016 - 2022

Education

  • National Centre for Cell Science PhD
    2016 - 2022

Projects & Funding

Projects & funding information is unavailable.

Publications (13)